The entire audio recording can be heard at http://phx.corporate-ir.net/phoenix.zhtml?c=209336&p=irol-event...

Here is some stuff I found interesting...

MM:SS

08:08 "As our partner, Dexcom, noted on their conference call last week, we are in the early stages of development of an integrated system that utilizes our next generation pod and their fourth generation sensor. We anticipate that an FDA submission could occur sometime in the first half of 2012."

17:00
Question: "Does the next generation pod require a new PDM, or can patients use the existing one?"
Answer: "It requires a new PDM." ***note - don't panic--read q&a @ 29min below...***

21:04 "We believe our next generation product will be a 2012 event..." "I think as we get a little more definitive on the timeline we will articulate to the market...that we'll have an upgrade strategy. ...We have the capability of forcing the upgrade strategy on the market and what we will do is probably do it in first come, first served fashion... get in the queue, get on the product... It's a little different in Europe because everything is going through A distributor ...so they have a supply chain... they know what's going on in the individual countries, plus the backlog... that one we're trying to time a little bit better. The US market, we will articulate as soon as we get a clear understanding of the timeline, we will clearly articulate to the market what the upgrade strategy is. ...the first people on our product will be the first people to get the next generation."

29:
Question: "When you start shipping, will Abbott pay for some of those upgrades? How's that going to work? Are they going to cover that cost for you? Or is this going to be the patient will have to upgrade... if they are on a gen 1, or they bought in the last 12 months... into an upgrade program, what are you thinking at this point?"
Answer: "What we're planning on doing is we ultimately want everybody to have the benefit of this new product. Certainly there is some financial benefit for us to do so, so we will ultimately, over a period of time like a six to 12 month roll out, once we launch, here in the US for example, effectively move everybody over to the new product, so we will supply the customer with a brand new hand-held (PDM) to accompany the new product. Keep in mind that the savings that we will generate on that first reorder is enough to effectively offset the cost of the hand-held (PDM). So in the first quarter of launch there won't be any margin improvement because they'll net each other to zero, but beyond that, we will receive all the margin improvement that we've been talking about. From an ROI perspective, that's a pretty quick payback."